-

Eurofins Environment Testing Eaton Analytical Launches Groundbreaking Chloronitramide Anion Testing for Drinking Water

POMONA, Calif.--(BUSINESS WIRE)--Eurofins Environment Testing Eaton Analytical, part of the Eurofins Environment Testing network of laboratories in the US and a leader in water quality analysis, has introduced a cutting-edge method to detect chloronitramide anion, a newly identified disinfection byproduct (DBP), in drinking water. This innovation follows a pivotal study published in Science that identified chloronitramide anion as a previously unidentified decomposition product of chloramine disinfection.

Chloramine disinfection, also known as chloramination, is used by approximately one-third of US drinking water utilities as a primary or secondary disinfection process to minimize the formation of regulated disinfection byproducts (DBPs) such as total trihalomethanes (TTHMs) and haloacetic acids (HAA5).

A recent breakthrough discovery by Fairey et al. discovered the presence of chloronitramide anion in chloraminated drinking water samples, at a concentration of up to 120 µg/L. Eurofins Environment Testing Eaton Analytical, in collaboration with Julian Fairey from the University of Arkansas, has developed an ultra-sensitive and precise testing method utilizing advanced analytical techniques to analyze chloronitramide anion in drinking water. While its impact on human health remains under investigation, chloronitramide anion shares structural similarities with some highly toxic compounds, which raises important questions about its associated potential risks.

About the Eurofins Environment Testing network of laboratories in the US
The Eurofins Environment Testing network of laboratories in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities. With a focus on client service, regulatory compliance and defensible data, the Eurofins Environment Testing network of laboratories in the US performs analysis of drinking water, groundwater, seawater, soil, asbestos, oil, grease, air and tissue using state-of-the-art analytical methods to assess quality and impact on health and the environment. For further information, please visit: www.EurofinsUS.com/Env

About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With ca. 62,000 staff across a network of more than 900 laboratories in over 1,000 companies in 62 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

Contacts

For further information:
Brooke MAHARG
Brooke.Maharg@ET.EurofinsUS.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For further information:
Brooke MAHARG
Brooke.Maharg@ET.EurofinsUS.com

More News From Eurofins

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/02/2026 FR0014000MR3 10 000 68.3375 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/02/2026 FR0014000MR3 10 000 67.9091 XPAR EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Viracor BioPharma Expands Bioanalytical Capabilities

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical...

Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is pleased to announce that its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development collaboration project focused on advancing a transformative approach for next-generation ADC (antibody-drug conjugate) production to meet the growing demand for targeted therapeutics. As part of this initia...
Back to Newsroom